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Unreliable estimation of 
prevalence of fetal 
alcohol syndrome 
Svetlana Popova and colleagues 
(March, 2017)1 sought to estimate 
the global, regional, and national 
prevalence of alcohol use during 
pregnancy and fetal alcohol syndrome 
(FAS). The authors reviewed inter-
national literature from 1984 for 
country-specific quantitative studies 
and for countries with one or no 
studies they predicted gestational 
alcohol use prevalence by fractional 
response regression modelling and 
prevalence of FAS by an estimated 
quotient for the average number of 
women consuming alcohol during 
pregnancy per one case of FAS. For 
estimation of FAS prevalence, Italy 
was reported to be among the five 
countries worldwide with the highest 
prevalence of FAS per 10 000 people.
On the basis of our involvement in 
studies about national prevalence of 
gestational alcohol consumption and 
consequent prenatal exposure to this 
teratogen,2–5 we have to disagree with 
the estimates reported by the authors. 
First, according to WHO,6 Italy is 
the country with the lowest annual 
consumption of alcohol per capita 
(6·7 litres), lowest percentage of 
women with alcohol use disorders 
(0·8%) and alcohol abuse dependence 
(0·4%), and the highest number of 
female lifetime abstainers (37·5%) 
among all European countries with 
the exclusion of eastern states with a 
prevalent Muslim faith (eg, Azerbaijan, 
Kyrgyzstan, and Tajikistan). 
Second, only a few somewhat dated 
studies have investigated alcohol 
consumption during pregnancy in 
Italy,7–10 which include a limited number 
of pregnant women in selected cities, 
and are therefore not representative of 
the general population. Additionally, 
self-reported drinking during 
pregnancy varied from one or more 
drinks per day to one per month or less 
in these studies.
That women’s self-reporting of 
drinking varies has been confirmed by 
our studies2–5 on objective assessment 
of prenatal exposure to alcohol 
through measurement of biomarkers 
in neonatal meconium. The overall 
prevalence of newborns prenatally 
exposed to maternal alcohol was 
7·9%, within the 20–30% of pregnant 
women that self-reported drinking 
during pregnancy. Fetal exposure 
varied between 0% and 10% along 
the Italian peninsula with an isolated 
maximum value of 29·4% in Rome 
capital. 
Furthermore, an observational, 
cross-sectional case-control study11 
used by the authors of 976 children 
aged 6–10 years, from an area of small 
towns immersed in the countryside 
in central Italy, estimated the rate of 
FAS as between 4 per 1000 and 12 
per 1000 people in 2011. These rates 
cannot in any case be representative 
of the Italian population, because the 
study refers to very few individuals 
belonging to a specific biased sub-
urban, rural area of wine producers. 
We call on the national health 
community to recognise the need for a 
properly designed study on alcohol use 
during pregnancy, choosing a sample 
of Italian women representative of 
the general population with a targeted 
follow-up of newborns prenatally 
exposed by biomarker positivity to 
accurately calculate the prevalence 
of FAS cases. Any prediction based 
on non-reliable simulation or non-
generalisable data cannot be deemed 
worthy of trust. 
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